VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RCKT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
RCKTRocket Pharmaceuticals, Inc.
$4.07$444M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRCKTQuarterly Financials

Rocket Pharmaceuticals, Inc. (RCKT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Rocket Pharmaceuticals, Inc. (RCKT) quarterly income statement — complete revenue, gross profit & net income history

RCKT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold2.15M0000002.34M2.25M00000000000
COGS % of Revenue--------------------
Gross Profit-2.15M000000-2.34M-2.25M00000000000
Gross Margin %--------------------
Gross Profit Growth %---100%100%---------------
Operating Expenses46.37M43.96M52.25M71.15M64.39M62.69M69.42M71.37M65.12M63.28M65.43M68.76M62.19M69.08M58.49M54.21M42.56M44.33M49.65M34.05M
OpEx % of Revenue--------------------
Selling, General & Admin17.06M14.68M18.35M25.02M28.45M25.34M27.11M26.58M21.36M21.54M18.59M17.37M15.82M19.05M15.11M12.85M11.77M12.17M10.03M9.52M
SG&A % of Revenue--------------------
Research & Development31.45M29.35M34.07M42.66M35.94M37.36M42.31M44.79M43.76M41.74M46.84M51.38M46.37M50.04M43.38M41.36M30.79M32.16M39.62M24.53M
R&D % of Revenue--------------------
Other Operating Expenses-1000K-68K-172K1000K0000000000000000
Operating Income-48.51M-43.96M-52.25M-71.15M-64.39M-62.69M-69.42M-73.71M-67.38M-63.28M-65.43M-68.76M-62.19M-69.08M-58.49M-54.21M-42.56M-44.33M-49.65M-34.05M
Operating Margin %--------------------
Operating Income Growth %24.66%29.88%24.74%3.48%4.43%0.92%-6.11%-7.21%-8.33%8.4%-11.87%-26.83%-46.12%-55.83%-17.81%-59.22%-8.52%25.16%-81.28%-44.52%
EBITDA-46.37M-41.75M-49.01M-68.57M-61.4M-60.33M-67.03M-71.37M-65.12M-61.34M-63.67M-67.03M-60.52M-65.7M-56.87M-52.64M-41.26M-41.15M-48.84M-33.34M
EBITDA Margin %--------------------
EBITDA Growth %24.49%30.81%26.89%3.93%5.72%1.65%-5.29%-6.49%-7.6%6.63%-11.96%-27.32%-46.67%-59.67%-16.44%-57.89%-7.04%29.79%-80.12%-42.27%
D&A (Non-Cash Add-back)2.15M2.22M3.24M2.58M2.99M2.36M2.39M2.34M2.25M1.94M1.76M1.73M1.67M3.38M1.62M1.57M1.3M3.19M808K706K
EBIT-48.51M-39.23M-49.86M-68.45M-60.86M-59.85M-66.25M-69.17M-61.58M-59.19M-61.43M-65.23M-57.87M-67.34M-57.13M-53.54M-41.94M-42.98M-48.84M-33.55M
Net Interest Income1.02M2.92M-473K2.23M3.05M2.37M2.71M4.07M5.32M3.62M3.53M3.06M3.86M1.86M732K-192K-418K-414K-472K-477K
Interest Income1.49M6.23M02.7M3.53M2.84M3.18M4.54M5.79M4.09M4M3.52M4.33M2.33M1.35M669K623K849K806K501K
Interest Expense473K3.31M473K473K472K473K471K471K471K470K469K468K468K467K621K861K1.04M1.26M1.28M978K
Other Income/Expense917K1.43M1.92M2.23M3.05M2.37M2.71M4.07M5.32M3.62M3.53M3.06M3.86M2.36M732K-192K-418K86K-472K-477K
Pretax Income-47.59M-42.54M-50.33M-68.92M-61.33M-60.33M-66.72M-69.65M-62.05M-59.66M-61.9M-65.7M-58.34M-66.72M-57.76M-54.4M-42.98M-44.25M-50.12M-34.52M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-47.59M-42.54M-50.33M-68.92M-61.33M-60.33M-66.72M-69.65M-62.05M-59.66M-61.9M-65.7M-58.34M-66.72M-57.76M-54.4M-42.98M-44.25M-50.12M-34.52M
Net Margin %--------------------
Net Income Growth %22.4%29.49%24.56%1.04%1.16%-1.12%-7.79%-6%-6.38%10.59%-7.17%-20.77%-35.72%-50.8%-15.24%-57.57%-6.98%27.36%-72.35%-37.88%
Net Income (Continuing)-47.59M-42.54M-50.33M-68.92M-61.33M-60.33M-66.72M-69.65M-62.05M-59.66M-61.9M-65.7M-58.34M-66.72M-57.76M-54.4M-42.98M-44.25M-50.12M-34.52M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.42-0.38-0.45-0.62-0.56-0.62-0.71-0.74-0.66-0.64-0.75-0.82-0.69-0.88-0.86-0.83-0.67-0.69-0.79-0.55
EPS Growth %25%38.71%36.62%16.22%15.15%3.13%5.33%9.76%4.35%27.27%12.79%1.2%-2.99%-27.54%-8.86%-50.91%-3.08%37.27%-49.06%-22.22%
EPS (Basic)-0.42-0.38-0.45-0.62-0.56-0.62-0.71-0.74-0.66-0.64-0.75-0.82-0.69-0.88-0.86-0.83-0.67-0.69-0.79-0.55
Diluted Shares Outstanding112.13M111.12M111.57M111.02M110.09M97.53M94.16M93.75M93.55M93.34M82.64M80.47M79.45M72.89M66.22M65.48M64.51M64.47M63.83M63.06M
Basic Shares Outstanding112.13M111.12M111.57M111.02M110.09M97.53M94.16M93.75M93.55M93.34M82.64M80.47M79.45M72.89M66.22M65.48M64.51M64.47M63.83M63.06M
Dividend Payout Ratio--------------------